Temobela belongs to the group of anti-cancer and immunosuppressive drugs, used to treat neuroblastoma. Let's learn about Temobela drug information through the article below.

According to the 2016 WHO classification of tumors of the central nervous system, testing for mutations in the IDH1 and IDH2 genes is recommended for all patients with grade II–III gliomas and GBM diagnosed before the age of 55. The most common mutation of IDH1 is R132H, which can be detected by immunohistochemistry (IHC). The remaining mutations of the IDH1 and IDH2 genes can be detected by DNA sequencing.

Central nervous system tumors are not the name of a disease, but rather a group of diseases, including both benign and malignant tumors. What types of CNS tumors are common in children, let's find out through the article below.

Neuroblastoma is a disease found in children under 5 years of age. Like other cancers, neuroblastoma progresses through different stages. Understanding the stages of disease development will help patients with neuroblastoma receive proper treatment and recover early.

While primary brain tumors form in the brain itself or in tissues near the brain, secondary brain tumors arise when normal cells experience errors (mutations) in their DNA. Currently, treatment options depend on the type of brain tumor a person has, as well as its size and location.

Carmustine is an anticancer drug used to treat certain types of brain tumors; glioblastoma, brain stem glioma, astrocytoma, ependymoma,.... Learn the uses of Carmustine through the article below.

Glioblastoma is a malignant tumor that progresses rapidly and has a poor prognosis. If the disease is not treated promptly and properly, the patient will soon fall into a serious condition.